Fewer hospitalizations, death with neutralizing monoclonal antibodies for COVID-19

Treatment with neutralizing monoclonal antibodies in COVID-19 outpatients resulted in fewer hospital admissions and deaths vs. no antibody treatment, according to results published in CHEST.